Wed, July 26, 2017
Tue, July 25, 2017
Mon, July 24, 2017
Fri, July 21, 2017
Thu, July 20, 2017
Wed, July 19, 2017
Tue, July 18, 2017
Mon, July 17, 2017
Fri, July 14, 2017
Thu, July 13, 2017
Wed, July 12, 2017
Tue, July 11, 2017
Mon, July 10, 2017
Fri, July 7, 2017
Thu, July 6, 2017
Wed, July 5, 2017
Mon, July 3, 2017
Fri, June 30, 2017
Thu, June 29, 2017
Wed, June 28, 2017
Tue, June 27, 2017

David Amsellem Downgraded (SUPN) to Hold on, Jul 17th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. em-downgraded-supn-to-hold-on-jul-17th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold on, Jul 17th, 2017.

David has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ken Trbovich of "Janney Montgomery Scott" Initiated at Hold and Held Target at $47 on, Friday, July 14th, 2017